Adams PLC - Half-year Report
Adams plc
("Adams" or the "Company")
Interim Results for the Six Months ended
Chairman's Statement
Adams generated a net profit of
The half year profit of
During the half year, the Company spent
The carrying value of the Company's equity investments at
The Company held cash balances of
Net assets increased to
Business model and investing policy
Adams is an investing company with an investing policy under which the Board is seeking to acquire interests in special situation investment opportunities that have an element of distress, dislocation, dysfunction or other special situation attributes and that the Board perceives to be undervalued. The principal focus is in the small to middle-market capitalisation sectors in the
Investment Portfolio
The principal listed investments held by the Company at
Niox is an AIM listed global medical device company focused on point of care FeNO testing for the diagnosis and management of asthma. The NIOX VERO® device is the market leader in point of care testing and is approved and reimbursed in most major markets. The group is progressing its transition to a distributor led model with new arrangements in the
C4XD is a pioneering drug discovery company combining its enhanced DNA-based target identification and candidate molecule design capabilities to efficiently deliver world‑leading medicines which are developed by licensing partners. C4XD has a number of existing partnership deals including a milestone and royalties out-licensing agreement with Sanofi for its IL-17A inhibitor programme worth up to
Seeing Machines is an AIM listed industry leader in advanced computer vision technologies. The company designs Artificial Intelligence / AI powered operator monitoring systems using camera-based optics and embedded processing to improve transport safety in automotive, commercial fleet, aviation, rail and off-road markets. The technology incorporates warnings when human state attention impairment is identified, in order to re-engage the operator or driver. Seeing Machines continues to invest in R&D and grow as an automotive leader in such technology having now won contracts with a total of 10 automotive Tier 1 global customers covering 15 automotive driver monitoring safety ("DMS") programmes. A total of 6 OEM programs have now started production, and at
Griffin Mining Limited, which is an AIM listed mining and investment company that has been the leader in foreign investment in mining in
Access Intelligence is an AIM listed
Oxehealth is a private company and an industry leader in vision-based patient monitoring and management systems. The company uses proprietary signal processing and computer vision to process normal digital video camera data to measure the vital signs and activity of patients in a number of different markets, primarily in Mental Health, Acute Hospital settings, Primary Care settings, Care Home, and Custodial facilities in both the
Telit is a private company and a global leader in Internet of Things (IoT) enablement. Telit has over twenty years of experience designing, building, and executing complex digital business. The company has an extensive portfolio of wireless connectivity modules, software platforms and global IoT connectivity services, including cellular plans and cloud and data orchestration software. These have empowered hundreds of millions of connected 'things' to date, and are trusted by thousands of direct and indirect customers, globally. On
In addition to the above investments, at
Outlook
World economies are currently facing many risks and geopolitical uncertainties including the terrible current conflicts in
Difficult and volatile financial market conditions subsequent to our
In view of the above risks and uncertainties, your Board will continue to maintain a rigorous and highly selective investment approach, coupled with strict cost control with a view to delivering additional value for shareholders going forward. We remain confident in the underlying fundamentals, technologies and long-term potential for growth at the companies within our investment portfolio.
Chairman
Certain information contained in this announcement would have been deemed inside information for the purposes of
The Directors of the Company take responsibility for this announcement.
Enquiries:
|
Adams plc |
|
|
|
Tel: +44 1534 719 761 |
|
|
|
|
Nomad |
|
|
Cairn Financial Advisers LLP |
|
|
|
Tel: +44 207 213 0880 |
|
|
|
|
Broker |
|
|
Peterhouse Capital Limited |
|
|
|
Tel: +44 207 469 0930 |
Caution regarding forward looking statements
Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.
STATEMENT OF COMPREHENSIVE INCOME
FOR THE SIX MONTH PERIOD TO
|
|
|
6 months ended |
Year ended |
6 months ended |
|
|
Note |
(Unaudited) |
(Audited) |
(Unaudited) |
|
|
|
£'000 |
£'000 |
£'000 |
|
Gain/(loss) on investments |
6 |
348 |
(2,188) |
(947) |
|
Dividend income |
|
39 |
- |
- |
|
Investment return |
|
387 |
(2,188) |
(947) |
|
|
|
|
|
|
|
Expenses and other income |
|
|
|
|
|
Administrative expenses |
|
(96) |
(182) |
(82) |
|
|
|
|
|
|
|
Operating loss |
|
291 |
(2,370) |
(1,029) |
|
|
|
|
|
|
|
Interest income |
|
1 |
- |
- |
|
|
|
|
|
|
|
Profit/(loss) before taxation |
292 |
(2,370) |
(1,029) |
|
|
|
|
|
|
|
|
Taxation |
|
- |
- |
- |
|
|
|
|
|
|
|
Profit/(loss) |
|
|
|
|
|
for the period |
|
292 |
(2,370) |
(1,029) |
|
|
|
|
|
|
|
Basic and diluted gain/(loss) per share |
11 |
0.20p |
(1.62)p |
(0.70)p |
There are no other items of comprehensive income or loss.
The notes form an integral part of the financial statements.
STATEMENT OF FINANCIAL POSITION
AS AT
|
|
|
|
As at |
As at |
As at |
|
|
|
|
(Unaudited) |
(Audited) |
(Unaudited) |
|
|
Note |
|
£'000 |
£'000 |
£'000 |
|
Assets |
|
|
|
|
|
|
Non-current assets |
|
|
|
|
|
|
Investments |
7 |
|
5,312 |
5,095 |
6,300 |
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
Trade and other receivables |
8 |
|
4 |
11 |
4 |
|
Cash and cash equivalents |
|
|
115 |
47 |
163 |
|
Total current assets |
|
|
119 |
58 |
167 |
|
|
|
|
|
|
|
|
Total assets |
|
|
5,431 |
5,153 |
6,467 |
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
Trade and other payables |
9 |
|
(29) |
(43) |
(16) |
|
Total liabilities |
|
|
(29) |
(43) |
(16) |
|
|
|
|
|
|
|
|
Net current assets |
|
|
90 |
15 |
151 |
|
|
|
|
|
|
|
|
Net assets |
|
|
5,402 |
5,110 |
6,451 |
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
Called up share capital |
10 |
|
1,459 |
1,459 |
1,459 |
|
Share premium |
10 |
|
3,425 |
3,425 |
3,425 |
|
Accumulated gains |
|
|
518 |
226 |
1,567 |
|
Total shareholder equity |
|
|
5,402 |
5,110 |
6,451 |
|
|
|
|
|
|
|
The notes form an integral part of the financial statements.
The condensed interim financial statements were approved and authorised for issue by the Board of Directors on
Chairman
STATEMENT OF CHANGES IN EQUITY
FOR THE SIX MONTH PERIOD TO
|
|
Share Capital |
Share Premium |
Accumulated Gains |
Total |
|
|
£'000 |
|
£'000 |
£'000 |
|
|
|
|
|
|
|
At |
1,459 |
3,425 |
2,596 |
7,480 |
|
|
|
|
|
|
|
Total comprehensive loss for period |
- |
- |
(1,029) |
(1,029) |
|
|
|
|
|
|
|
At |
1,459 |
3,425 |
1,567 |
6,451 |
|
|
|
|
|
|
|
Total comprehensive loss for period |
- |
- |
(1,341) |
(1,341) |
|
|
|
|
|
|
|
At |
1,459 |
3,425 |
226 |
5,110 |
|
|
|
|
|
|
|
Total comprehensive gain for period |
- |
- |
292 |
292 |
|
|
|
|
|
|
|
At |
1,459 |
3,425 |
518 |
5,402 |
The notes form an integral part of the financial statements.
STATEMENT OF CASH FLOWS
FOR THE SIX MONTH PERIOD TO
|
|
6 months ended 30 Sep 2023 |
Year ended |
6 months ended 30 Sep 2022 |
|
|
(Unaudited) |
(Audited) |
(Unaudited) |
|
|
£'000 |
£'000 |
£'000 |
|
|
|
|
|
|
Profit/(loss) for the period |
292 |
(2,370) |
(1,029) |
|
Unrealised (gain)/loss on revaluation of investments |
(342) |
2,203 |
947 |
|
Realised gain on disposal of investments |
(6) |
(15) |
- |
|
Decrease in trade and other receivables |
7 |
1 |
8 |
|
(Decrease)/increase in trade and other payables |
(14) |
18 |
(9) |
|
|
|
|
|
|
Net cash outflows from operating activities |
(63) |
(163) |
(83) |
|
|
|
|
|
|
Cash flows from investing activities |
|
|
|
|
Purchase of investments |
(211) |
(1,216) |
(625) |
|
Proceeds from sales of investments |
342 |
555 |
- |
|
|
|
|
|
|
Net cash inflows/(outflows) from investing activities |
131 |
(661) |
(625) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase/(decrease) in cash and cash equivalents |
68 |
(824) |
(708) |
|
|
|
|
|
|
Cash and cash equivalents at beginning of period |
47 |
871 |
871 |
|
|
|
|
|
|
Cash and cash equivalents at end of period |
115 |
47 |
163 |
|
|
|
|
|
The notes form an integral part of the financial statements.
NOTES TO THE FINANCIAL STATEMENTS
FOR THE SIX MONTH PERIOD TO
1 General information
Adams Plc ("the Company") is a company incorporated in the
2 Basis of preparation
The interim financial statements of Adams Plc are unaudited condensed financial statements for the six months ended
These interim condensed financial statements have been prepared on the basis of the accounting policies expected to apply for the financial year to
The interim financial statements do not include all of the information required for full annual financial statements and do not comply with all the disclosures in IAS 34 'Interim Financial Reporting', and should be read in conjunction with the Company's annual financial statements to
The preparation of financial statements in conformity with IFRS as adopted by the
3 Going concern
Information on the business environment, financial position and the factors underpinning the Company's future prospects and portfolio are included in the Chairman's Statement. The Directors have considered their obligation in relation to the assessment of the going concern of the Company and have reviewed the current cash forecasts and assumptions as well as the main risk factors facing the Company. Accordingly, the going concern basis has been adopted in the preparation of the financial statements.
4 Significant accounting policies
The accounting policies adopted are consistent with those followed in the preparation of the annual financial statements of Adams Plc for the year ended
5 Segment reporting
Operating segments for Adams Plc are reported based on the financial information provided to the Board, which is used to make strategic decisions. The Directors are of the opinion that under IFRS 8 'Operating segments' the Company has only one reportable segment, being Investment Return. The Board assesses the performance of the operating segment based on financial information which is measured and presented in a manner consistent with that in the financial statements.
6 Investment Return
The principal sources of revenue for the Company in the period to
|
|
6 months ended |
Year ended |
6 months ended |
|
|
£'000 |
£'000 |
£'000 |
|
Unrealised gain/(loss) on investments |
6 |
(2,203) |
(947) |
|
Realised gains on investments |
342 |
15 |
- |
|
Total gain/(loss) on investments |
348 |
(2,188) |
(947) |
|
Dividend Income |
39 |
- |
- |
|
Investment return |
387 |
(2,188) |
(947) |
7 Investments
An analysis of movements in the value of the Company's investments is as follows:
|
|
Quoted Equity Shares |
Unquoted Equity Shares |
Derivative Trading Asset |
Total |
|
|
£'000 |
£'000 |
£'000 |
£'000 |
|
Fair value at |
4,693 |
1,920 |
9 |
6,622 |
|
Additions at cost |
625 |
- |
- |
625 |
|
Unrealised revaluation losses |
(938) |
- |
(9) |
(947) |
|
Fair value at |
4,380 |
1,920 |
- |
6,300 |
|
Additions at cost |
591 |
- |
- |
591 |
|
Disposals |
(540) |
- |
- |
(540) |
|
Trasferred to unquoted equity |
(103) |
103 |
- |
- |
|
Unrealised revaluation losses |
(758) |
(523) |
25 |
(1,256) |
|
Fair value at |
3,570 |
1,500 |
25 |
5,095 |
|
Additions at cost |
211 |
- |
- |
211 |
|
Disposals |
(336) |
- |
- |
(336) |
|
Unrealised revaluation gains |
367 |
- |
(25) |
342 |
|
Fair value at |
3,812 |
1,500 |
- |
5,312 |
8 Trade and other receivables
|
|
As at |
As at |
As at 30 Sep 2022 |
|
|
£'000 |
£'000 |
£'000 |
|
Prepayments |
4 |
11 |
4 |
|
|
4 |
11 |
4 |
The carrying amount of prepayments is approximate to their fair value.
9 Trade and other payables
|
|
As at |
As at |
As at 30 Sep 2022 |
|
|
£'000 |
£'000 |
£'000 |
|
Trade payables |
11 |
8 |
7 |
|
Accruals and other creditors |
18 |
35 |
9 |
|
|
29 |
43 |
16 |
The carrying amount of trade and other payables approximates to their fair value.
10 Share capital
|
Ordinary shares of |
Number of shares |
Share capital £'000 |
Share premium |
|
Authorised ordinary shares At |
350,000,000 |
3,500 |
|
|
Allotted, issued and fully paid ordinary shares At |
145,859,231 |
1,459 |
3,425 |
11 Earnings/(loss) per share
The basic earnings or loss per share is calculated by dividing the profit or loss after tax attributable to equity shareholders by the weighted average number of Ordinary Shares in issue during the period:
|
|
6 months ended 30 Sep 2023 |
Year ended |
6 months ended |
|
|
|
|
|
|
Gain/(loss) after tax attributable to equity holders of the Company (£'000) |
292 |
(2,370) |
(1,029) |
|
|
|
|
|
|
Weighted average number of Ordinary Shares |
145,859,213 |
145,859,231 |
145,859,231 |
|
|
|
|
|
|
Basic and diluted earnings/(loss) per share |
0.20p |
(1.62)p |
(0.70)p |
There were no potentially dilutive shares in issue as at
12 Half year interim report
A copy of this half year interim report, as well as the annual statutory accounts to
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE